N-Methoxy-N-methyloxolane-3-carboxamide

Catalog No. :
ACCEML125
CAS No. :
766539-67-7
Molecular Formula :
C7H13NO3
Molecular Weight :
159.18

IUPAC Name:N-methoxy-N-methyltetrahydrofuran-3-carboxamide

N-Methoxy-N-methyloxolane-3-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$311.00Login to see priceInquiryInquiry
1g90%$700.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Methoxy-N-methyloxolane-3-carboxamide
IUPAC NameN-methoxy-N-methyltetrahydrofuran-3-carboxamide
MDL No.MFCD18841349
Molecular FormulaC7H13NO3
Molecular Weight159.18
SMILESO=C(C1COCC1)N(OC)C
InChI KeyDKBCSKRFSZEHFE-UHFFFAOYSA-N
Synonym3-Furancarboxamide,tetrahydro-N-methoxy-N-methyl-(9CI);N-Methoxy-N-methyl tetrahydro-3-furamide, tech grade;tetrahydro-N-methoxy-N-methyl-3-Furancarboxamide;N-methoxy-N-methyltetrahydrofuran-3-carboxamide;3-Furancarboxamide, tetrahydro-N-methoxy-N-methyl-;N-Methoxy-N-methyl tetrahydro-3-furamide (Technical Grade);3-Furancarboxamide,tetrahydro-N-methoxy-N-methyl-(9Cl)
CAS No.766539-67-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACCEML125 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCLNE518 route compound structure diagram
    ACCLNE5186638-79-5 In Stock
  2. Plus
  3. ACYUBF208 route compound structure diagram
    ACYUBF20889364-31-8 In Stock
  4. Then
  5. ACCEML125 route product structure diagram
    ACCEML125766539-67-7
Inquiry

2. ACCEML125 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYUBF208 route compound structure diagram
    ACYUBF20889364-31-8 In Stock
  2. Then
  3. ACCEML125 route product structure diagram
    ACCEML125766539-67-7
Inquiry

Comments (0)